Liu W et al. (2011), TRPM7 regulates gastrulation during vertebrate ...

XB-ART-43022

Dev Biol 2011 Feb 15;3502:348-57. doi: 10.1016/j.ydbio.2010.11.034.

Show Gene links Show Anatomy links

TRPM7 regulates gastrulation during vertebrate embryogenesis.

Liu W , Su LT , Khadka DK , Mezzacappa C , Komiya Y , Sato A , Habas R , Runnels LW .

???displayArticle.abstract???
During gastrulation, cells in the dorsal marginal zone polarize, elongate, align and intercalate to establish the physical body axis of the developing embryo. Here we demonstrate that the bifunctional channel-kinase TRPM7 is specifically required for vertebrate gastrulation. TRPM7 is temporally expressed maternally and throughout development, and is spatially enriched in tissues undergoing convergent extension during gastrulation. Functional studies reveal that TRPM7's ion channel, but not its kinase domain, specifically affects cell polarity and convergent extension movements during gastrulation, independent of mesodermal specification. During gastrulation, the non-canonical Wnt pathway via Dishevelled (Dvl) orchestrates the activities of the GTPases Rho and Rac to control convergent extension movements. We find that TRPM7 functions synergistically with non-canonical Wnt signaling to regulate Rac activity. The phenotype caused by depletion of the Ca(2+)- and Mg(2+)-permeant TRPM7 is suppressed by expression of a dominant negative form of Rac, as well as by Mg(2+) supplementation or by expression of the Mg(2+) transporter SLC41A2. Together, these studies demonstrate an essential role for the ion channel TRPM7 and Mg(2+) in Rac-dependent polarized cell movements during vertebrate gastrulation.

???displayArticle.pubmedLink??? 21145885
???displayArticle.pmcLink??? PMC3292586
???displayArticle.link??? Dev Biol
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: chrd daam1 dvl1 dvl2 gsc rac1 rho rho.2 slc41a2 tbxt trpm6 trpm7 wnt8a
???displayArticle.morpholinos??? trpm7 MO1 trpm7 MO2

???attribute.lit??? ???displayArticles.show???

	Fig. 1. XTRPM7 is required for gastrulation. (A) Expression pattern of XTRPM7 at selected developmental stages as analyzed by whole-mount in situ hybridization using a TRPM7 anti-sense probe. A sense probe was used as a negative control. XTRPM7 is expressed at higher levels in the dorsal mesoderm and neural plate (stars and arrowheads, respectively), which is associated with dynamic morphogenesis movements. Arrows indicate the region where the embryo was vertically sectioned and examined. AP: Animal pole; VP: Vegetal pole; DV: dorsal view; TS: transverse section; LV: lateral view; ST: stage (B) Injection of TRPM7 RNA (2 ng) dorsally, but not ventrally, inhibited gastrulation resulting in embryos with curved axes, open neural folds, and reduced anterior structures. Dorsal injection of the kinase-dead TRPM71618D (TRPM7D, 2 ng), but not the channel-dead TRPM71047K (TRPM7-CD, 2 ng), produced a similar phenotype. In addition, dorsal injection of TRPM6 (2 ng) and the Mg2+ transporter SLC41A2 (2 ng) RNAs also produced gastrulation defects. Dorsal injection of XTRPM7 MOs (37.5 ng each) inhibited gastrulation, and this phenotype was rescued by co-injection of XTRPM7 MOs with TRPM7 RNA (400 pg), TRPM7-KD RNA (400 pg), and TRPM6 RNA (400 pg) as well as by SLC41A2 (Mg2+ transporter) RNA (400 pg). However, co-injection of TRPM7-CD RNA with the XTRPM7 MOs did not rescue the XTRPM7 MO-induced gastrulation phenotypes. Injections were performed into the dorsal or ventral marginal zone of the four-cell embryo, and the phenotypes were scored at the tadpole stage. (C) Quantification of the phenotypic results from overexpression of TRPM7 or depletion of XTRPM7; the number of embryos examined is shown above each bar.
	Fig. 2. Mg2+ is required for gastrulation. (A) Dorsal injection of XTRPM7 MOs (75 ng) in embryos cultured in 0.1MMR (0.1 mM Mg2+) inhibited gastrulation. Supplementation of Mg2+, but not Ca2+, into the culture media at 5 mM at stage 10.5 rescued the gastrulation phenotype. (B) Quantification of the effects of Mg2+ and Ca2+ supplementation on embryos injected with XTRPM7 MOs; the number of embryos is shown above each bar. (C) Embryos injected dorsally with XTRPM7 MOs or TRPM7 RNA had no defects in expression of mesodermal marker genes Chordin, Goosecoid, Xbra and XWnt8 as monitored by RT-PCR analysis; EF1-Î± was used as a loading control.
	Fig. 3. XTRPM7 is required for convergent extension movements. (A) Dorsal marginal zone (Keller) explant assay revealed that overexpression of TRPM7 (2 ng) and injection of XTRPM7 MOs inhibit convergent extension movements. Dominant negative Dishevelled (Xdd1, 2 ng) was used as a positive control. Inhibition of convergent extension produced by depletion of XTRPM7 was rescued by co-injection of XTRPM7 MOs with TRPM7 RNA (400 pg) and the Mg2+ transporter SLC41A2 (400 pg), as well as supplementation of the buffer with 5 mM Mg2+ but not 5 mM Ca2+. (B) Quantification of Keller explant assay; bars indicate the average length to width ratio of Keller explants and the number of explants analyzed is shown above each bar.
	Fig. 4. XTRPM7 is required for dorsal mesodermal cell polarization, elongation and alignment. (A) Confocal imaging analysis revealed that injection of TRPM7 RNA and XTRPM7 MOs inhibits dorsal mesodermal cell polarization and elongation. Control cells were labelled with EGFP-CAAX (green, 500 pg) and membrane-tethered Cherry (red, 500 pg) was co-injected with either TRPM7 RNA (2 ng), dominant negative Dishevelled (Xdd1) RNA (2 ng), XTRPM7 MOs (75 ng), or XTRPM7 MOs (75 ng) and TRPM7 RNA (400 pg). (B) Illustration of calculations of average length to width ratio and average angular deviation. Length to width ratio was measured by taking the length of the cell (red arrow) divided by the width of the cell (blue line). Angular orientation of the cell was measured by taking the absolute value of the angle of the red arrow in reference to the lateral axis (L) and was used for calculations of average angular deviation. (C) Injection of Xdd1 RNA and TRPM7 RNA or injection of the XTRPM7 MOs disrupted dorsal mesodermal cell elongation as quantified by the length/width ratio of cells. The error bars represent the standard deviation (s.d.) from at least three independent experiments and the number of cells examined is shown at the top of each bar. (D) Injection of Xdd1 RNA and TRPM7 RNA or injection of the XTRPM7 MOs disrupted alignment of dorsal mesodermal cells undergoing convergent extension. The error bars represent the s.d. from at least three independent experiments and the number of cells examined is shown at the top of each bar.
	Fig. 5. TRPM7 is required for regulation of Rac and non-canonical Wnt signaling.(A) Disruption of gastrulation produced by injection of XTRPM7 MOs (75 ng) can be suppressed by co-injection of dominant active Dishevelled (Î´DIX-Dvl) RNA (400 pg), but not by injection of Dishevelled lacking the DEP domain (Î´DEP-Dvl, 400 pg), whose deletion disrupts activation of the Rac component of the PCP pathway. (B) Quantification of the phenotypes observed with separate or co-injections of XTRPM7 MOs with Î´DIX-Dvl, and Î´DEP-Dvl RNAs. The number of embryos scored is indicated above each bar. (C) Co-injection of dominant negative Dishevelled (Xdd1) RNA (250 pg) and XTRPM7 MOs (25 ng) synergistically inhibit gastrulation but have little or no effect when injected separately. GFP RNA was injected at 250 pg. (D) Quantification of the phenotypes observed with separate or co-injections of XTRPM7 MOs with Xdd1. The number of embryos scored is indicated above each bar. (E) Co-injection of XTRPM7 MOs with dominant negative RacN17 RNA (500 pg), but not with C-Daam1 cDNA (250 pg), RNAs for dominant negative RhoN19 (500 pg) or with the dominant active mutants RacV12 (10 pg) and RhoV14 (10 pg), prevents the disruption of gastrulation caused by the XTRPM7 MOs. (F) Quantification of the phenotypes observed with separate or co-injections of XTRPM7 MOs with RacN17, RacV12, RhoN19 and RhoV14 RNAs and C-Daam1 cDNA. The number of embryos scored is indicated above each bar. (G) Co-injection of a low concentration of XTRPM7 MOs (25 ng) with control MO (25 ng) or with Daam1 MO (25 ng) did not produce synergistic gastrulation defects. (H) Quantification of the phenotypes observed with separate or co-injections of XTRPM7 MOs with control MO or Daam1 MO. The number of embryos scored is indicated above each bar.
	Fig. 6. TRPM7 regulates Rac but not Rho activation levels. (A) Western blot analysis and quantification of levels of activated Rac at stage 10.5 during gastrulation. Injection of 75 ng of XTRPM7 MOs increased levels of activated Rac, which could be prevented by co-injection of 500 pg of TRPM7 RNA. (B) Quantification of the results in (A), the error bars represent the s.d. from at least five independent experiments. (C) Western blot analysis and quantification of levels of activated Rho at stage 10.5 during gastrulation. Levels of activated Rho were unaffected by injection of XTRPM7 MOs or TRPM7 RNA. (D) Quantification of the results in (C); error bars represent the s.d. from at least four independent experiments.

References [+] :

Almonte, Gestational magnesium deficiency is deleterious to fetal outcome. 1999, Pubmed